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P U B L I S H E D B Y E L S E V I E R I N C .LettersAmbulatory Blood
Pressure Control and
Subclinical Left Ventricular
Dysfunction in Treated
Hypertensive SubjectsBlood pressure (BP) control in hypertensive patients
is crucial for reducing the risk of heart failure devel-
opment and may be particularly important in elderly
subjects, who have an especially high prevalence
of hypertension and risk of heart failure (1). Left
ventricular (LV) global longitudinal strain (GLS) is an
echocardiographic measure of LV systolic function
that can be an indicator of early subclinical cardiac
dysfunction, even when LV ejection fraction is
normal. The association of BP control with early
subclinical LV dysfunction according to GLS has not
been extensively studied, and it is also unknown
whether assessing BP control with ambulatory
blood pressure (ABP) monitoring is superior to us-
ing ofﬁce BP measurements in this regard. There-
fore, we investigated the association of BP control
with GLS by using ABP and ofﬁce BP criteria in aon of Uncontrolled Ofﬁce BP and ABP With Abnormal GLS
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The study cohort consisted of 394 treated hyper-
tensive patients (mean age 72  9 years; 63% women)
with LV ejection fraction$50% from the CABL (Cardiac
Abnormalities and Brain Lesion) study. The patients
underwent transthoracic echocardiography and ABP
monitoring. Uncontrolled ofﬁce BP was deﬁned as of-
ﬁce systolic blood pressure (SBP) $140 mm Hg and/or
diastolic blood pressure (DBP) $90 mm Hg; uncon-
trolled 24-h ABP as mean 24-h SBP$130 mmHg and/or
DBP $80 mm Hg; uncontrolled daytime ABP as mean
daytime SBP$135 mmHg and/or DBP$85 mmHg; and
uncontrolled night-time ABP as mean night-time
SBP $120 mm Hg and/or DBP $70 mm Hg (2).
Speckle-tracking analysis was performed on digital
echocardiographic images by using commercially
available software (QLAB Advanced Quantiﬁcation
Software version 8.1, Philips, Andover, Massachu-
setts). The GLS was calculated by averaging the nega-
tive peak of longitudinal strain of 12 LV segments from
the apical 4- and 2-chamber views. Abnormal GLS was
deﬁned as a GLS more than –14.7%, which is the 95th
percentile of the GLS distribution in the healthy
normotensive subjects from the CABL cohort (3).
Seventy-seven subjects (19.5%) had abnormal GLS.
Ofﬁce BP was uncontrolled in 188 subjects (47.7%),
and 24-h ABP was uncontrolled in 162 (41.1%).
Concordant classiﬁcation of BP control between ofﬁce
BP and 24-h ABP was identiﬁed only in 230 subjects
(58.4%; kappa ¼ 0.16; 95% conﬁdence interval [CI]:
0.06 to 0.26). Uncontrolled daytime and night-time
ABP were identiﬁed in 36.6% and 53.0% of partici-
pants, respectively.
In univariable logistic regression analyses, uncon-
trolled 24-h ABP was signiﬁcantly associated with
abnormal GLS (odds ratio: 2.95; 95% CI: 1.76 to 4.93;
p < 0.0001), whereas uncontrolled ofﬁce BP was not
(odds ratio: 1.41; 95% CI: 0.85 to 2.32; p ¼ 0.18). After
adjustment for age, diabetes mellitus, coronary artery
disease, and LV mass index, uncontrolled 24-h ABP
remained signiﬁcantly associated with abnormal GLS
(Figure 1). A signiﬁcant association with abnormal GLS
was also found by using either daytime or night-time
criteria (Figure 1).
We show, for the ﬁrst time, the superiority of ABP
control over ofﬁce BP control for the risk stratiﬁcation
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1409of treated hypertensive subjects for the presence of
subclinical LV systolic dysfunction. In a hypertensive
animal model, impairment of GLS occurred in parallel
with the accumulation of ﬁbrosis induced by pressure
overload in the LV subendocardium in the early
stage of hypertensive heart failure (4). Therefore, we
speculate that consistent reduction of LV pressure
overload throughout the 24 h by antihypertensive
medications might be important in delaying the
progression of LV systolic dysfunction and that ABP
control may be a better indicator of the effective
reduction of LV pressure overload than ofﬁce BP
control. Of note, inadequate ABP control was more
frequent at night than during the day in this cohort,
further underlining how ofﬁce BP does not provide an
adequate representation of BP values in a critical
period of the day.
Evaluating BP control by use of ABP monitoring,
but not by ofﬁce BP, may identify patients with
hypertension at higher risk of early LV systolic
dysfunction. Whether achieving BP control according
to ABP criteria may help decrease the risk of devel-
oping subclinical LV systolic dysfunction, and
possibly slow its progression to clinical heart failure,
is a hypothesis that deserves further investigation.Fusako Sera, MD
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tension 2014;63:500–6.Aortic Dissection After
Previous Aortic Valve
Replacement for Bicuspid
Aortic Valve DiseaseThe effect of bicuspid aortic valve (BAV) phenotype on
the future risk of type A aortic dissection is unknown.
On the basis of previous data (1), we hypothesized that
the risk of post–aortic valve replacement (AVR) aortic
dissection might be different in BAV insufﬁciency
versus BAV stenosis.
A meta-analysis was performed in accordance with
published guidelines (2). We conducted a systematic
search on PubMed, Embase, Ovid, and Google Scholar
by using the terms “aortic dissection,” “bicuspid
aortic valve,” “aortic valve replacement,” “previous
cardiac surgery,” and “bicuspid aortopathy.” The
search was limited to original adult human studies of
type A aortic dissection occurring after previous iso-
lated AVR surgery in patients with BAV disease and
known functional phenotype (i.e., insufﬁciency vs.
stenosis). Reports on post-AVR dissection in patients
with tricuspid aortic valve disease and after combined
procedures were excluded. Papers reporting aortic
dissection within 14 days of AVR were also excluded.
The primary endpoint was the risk of post-AVR
dissection in BAV insufﬁciency versus BAV stenosis.
All analyses were conducted using Comprehensive
Meta-Analysis version 2 (Biostat, Englewood, New
Jersey). Events were compared as odds ratios by us-
ing a 95% conﬁdence interval. A random effects
model was used to derive pooled estimates. Study-
speciﬁc estimates were calculated on the assump-
tion that type A dissection develops in 0.6% of
patients after AVR (3) and that patients undergoing
surgery for BAV disease are 6 to 8 times more likely to
present with aortic stenosis than with insufﬁciency
(4). Heterogeneity was evaluated, and a sensitivity
analysis was performed. Fixed-effect meta-regression
was performed to determine the modulating effect of
arterial hypertension/aortic diameters. Publication
bias was evaluated using a funnel plot and Begg and
Mazumdar’s rank correlation test.
The keyword-based search revealed 17,068 poten-
tial publications. After removal of 3,056 duplicate
